MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. (Q39407479)

11 September 2017

MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. (English)

1 reference

11 September 2017

1 reference

Jinhai Li

1

1 reference

11 September 2017

Yuanyuan Guo

2

1 reference

11 September 2017

Xiaodi Liang

3

1 reference

11 September 2017

Ming Sun

4

1 reference

11 September 2017

Guoliang Wang

5

1 reference

11 September 2017

Wei De

6

1 reference

11 September 2017

Wenxi Wu

7

1 reference

11 September 2017

22 January 2012

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

1 reference

11 September 2017

138

1 reference

11 September 2017

5

1 reference

11 September 2017

763-774

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-012-1154-x

11 September 2017

0 references

cites work

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA functions in animal development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Mutational analysis of the hCDC4 gene in gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Survival prediction of gastric cancer by a seven-microRNA signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNAs: critical regulators of development, cellular physiology and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Differentially expressed microRNAs in small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Early onset gastric cancer: on the road to unraveling gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Nature meets nurture: molecular genetics of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA expression profiling of single whole embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA dysregulation in gastric cancer: a new player enters the game

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1154-X

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22270966

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Loss of CDC4/FBXW7 in gastric carcinoma.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22270966

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22270966

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-012-1154-X

1 reference

11 September 2017

1 reference